Tools to fight the cataract epidemic: A review of experimental animal models that mimic age related nuclear cataract

Experimental Eye Research

Volumn 145, Issue , 2016, Pages 432-443

  Lim, Julie C ^a   Umapathy, Ankita ^a   Donaldson, Paul J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Animal models; Lens; Nuclear cataract

Indexed keywords

BLINDNESS; CATARACT; CATARACTOGENESIS; EPIDEMIC; EXPERIMENTAL ANIMAL; HUMAN; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VISUAL IMPAIRMENT; ANIMAL; DISEASE MODEL; LENS; MEDICAL RESEARCH; PATHOLOGY; PROCEDURES; STANDARDS;

ANIMALS; BIOMEDICAL RESEARCH; CATARACT; DISEASE MODELS, ANIMAL; HUMANS; LENS, CRYSTALLINE;

EID: 84951737362     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2015.09.007     Document Type: Review

References (163)

1. Abraham A.G., Cox C., West S. The differential effect of ultraviolet light exposure on cataract rate across regions of the lens. Investig. Ophthalmol. Vis. Sci. 2010, 51:3919-3923.
2. Age-Related Eye Disease Study Research G Risk factors associated with age-related nuclear and cortical cataract : a case-control study in the Age-Related Eye Disease Study. Ophthalmology 2001, 108:1400-1408. AREDS Report No. 5.
3. Al-Ghoul K.J., Costello M.J. Fiber cell morphology and cytoplasmic texture in cataractous and normal human lens nuclei. Curr. Eye Res. 1996, 15:533-542.
4. Al-Ghoul K.J., Lane C.W., Taylor V.L., Fowler W.C., Costello M.J. Distribution and type of morphological damage in human nuclear age-related cataracts. Exp. Eye Res. 1996, 62:237-251.
5. Anderson E.I., Spector A. The state of sulfhydryl groups in normal and cataractous human lens proteins. I. Nuclear region. Exp. Eye Res. 1978, 26:407-417.
6. Ashida Y., Takeda T., Hosokawa M. Protein alterations in age-related cataract associated with a persistent hyaloid vascular system in senescence-accelerated mouse (SAM). Exp. Eye Res. 1994, 59:467-473.
7. 2 in emory mouse cataract. Investig. Ophthalmol. Vis. Sci. 1996, 37. 2758-2758.
8. Bhuyan K.C., Bhuyan D.K., Kuck J.F., Kuck K.D., Kern H.L. Increased lipid peroxidation and altered membrane functions in Emory mouse cataract. Curr. Eye Res. 1982, 2:595-606.
9. Biju P.G., Rooban B.N., Lija Y., Devi V.G., Sahasranamam V., Abraham A. Drevogenin D prevents selenite-induced oxidative stress and calpain activation in cultured rat lens. Mol. Vis. 2007, 13:1121-1129.
10. Bloemendal H., de Jong W., Jaenicke R., Lubsen N.H., Slingsby C., Tardieu A. Ageing and vision: structure, stability and function of lens crystallins. Prog. Biophys. Mol. Biol. 2004, 86:407-485.
11. Bond J., Green C., Donaldson P., Kistler J. Liquefaction of cortical tissue in diabetic and galactosemic rat lenses defined by confocal laser scanning microscopy. Investig. Ophthalmol. Vis. Sci. 1996, 37:1557-1565.
12. Borchman D., Giblin F.J., Leverenz V.R., Reddy V.N., Lin L.R., Yappert M.C., Tang D., Li L. Impact of aging and hyperbaric oxygen in vivo on guinea pig lens lipids and nuclear light scatter. Investig. Ophthalmol. Vis. Sci. 2000, 41:3061-3073.
13. Bourne R.R., Stevens G.A., White R.A., Smith J.L., Flaxman S.R., Price H., Jonas J.B., Keeffe J., Leasher J., Naidoo K., Pesudovs K., Resnikoff S., Taylor H.R. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob. Health 2013, 1:e339-349. Vision Loss Expert G.
14. Boyle D.L., Takemoto L.J. Confocal microscopy of human lens membranes in aged normal and nuclear cataracts. Investig. Ophthalmol. Vis. Sci. 1997, 38:2826-2832.
15. Brian G., Taylor H. Cataract blindness-challenges for the 21st century. Bull. World Health Organ 2001, 79:249-256.
16. Calvin H.I., Medvedovsky C., David J.C., Broglio T.M., Hess J.L., Fu S.C.J., Worgul B.V. Rapid deterioration of lens fibers in Gsh-depleted mouse pups. Investig. Ophthalmol. Vis. Sci. 1991, 32:1916-1924.
17. Calvin H.I., Medvedovsky C., Worgul B.V. Near-total glutathione depletion and age-specific cataracts induced by buthionine sulfoximine in mice. Science 1986, 233:553-555.
18. Calvin H.I., Patel S.A., Zhang J.P., Li M.Y., Fu S.C. Progressive modifications of mouse lens crystallins in cataracts induced by buthionine sulfoximine. Exp. Eye Res. 1992, 54:611-619.
19. Calvin H.I., von Hagen S., Hess J.L., Patel S.A., Fu S.C. Lens GSH depletion and electrolyte changes preceding cataracts induced by buthionine sulfoximine in suckling mice. Exp. Eye Res. 1992, 54:621-626.
20. Calvin H.I., Zhu G.-P., Wu J.-X., Banerjee U., Fu J.S.C. Progression of mouse buthionine sulfoximine cataracts in vitro is inhibited by thiols or ascorbate. Exp. Eye Res. 1997, 65:341-347.
21. Chatterjee A., Milton R.C., Thyle S. Prevalence and aetiology of cataract in Punjab. Br. J. Ophthalmol. 1982, 66:35-42.
22. Chen Y.C., Reid G.E., Simpson R.J., Truscott R.J. Molecular evidence for the involvement of alpha crystallin in the colouration/crosslinking of crystallins in age-related nuclear cataract. Exp. Eye Res. 1997, 65:835-840.
23. Chevez-Barrios P., Wiseman A.L., Rojas E., Ou C.N., Lieberman M.W. Cataract development in gamma-glutamyl transpeptidase-deficient mice. Exp. Eye Res. 2000, 71:575-582.
24. Coghlan S.D., Augusteyn R.C. Changes in the distribution of proteins in the aging human lens. Exp. Eye Res. 1977, 25:603-611.
25. Coroneo M.T., Muller-Stolzenburg N.W., Ho A. Peripheral light focusing by the anterior eye and the ophthalmohelioses. Ophthalmic Surg. 1991, 22:705-711.
26. Costello M.J., Johnsen S., Metlapally S., Gilliland K.O., Frame L., Balasubramanian D. Multilamellar spherical particles as potential sources of excessive light scattering in human age-related nuclear cataracts. Exp. Eye Res. 2010, 91:881-889.
27. Costello M.J., Oliver T.N., Cobo L.M. Cellular architecture in age-related human nuclear cataracts. Investig. Ophthalmol. Vis. Sci. 1992, 33:3209-3227.
28. Cruickshanks K.J., Klein B.E., Klein R. Ultraviolet light exposure and lens opacities: the Beaver Dam Eye Study. Am. J. Public Health 1992, 82:1658-1662.
29. David L.L., Shearer T.R. State of sulfhydryl in selenite cataract. Toxicol. Appl. Pharmacol. 1984, 74:109-115.
30. David L.L., Varnum M.D., Lampi K.J., Shearer T.R. Calpain II in human lens. Investig. Ophthalmol. Vis. Sci. 1989, 30:269-275.
31. Dillon J. Sunlight exposure and cataract. Jama 1999, 281:229. author reply 230.
32. Dilsiz N., Olcucu A., Atas M. Determination of calcium, sodium, potassium and magnesium concentrations in human senile cataractous lenses. Cell Biochem. Funct. 2000, 18:259-262.
33. Duncan G., Bushell A.R. Ion analyses of human cataractous lenses. Exp. Eye Res. 1975, 20:223-230.
34. Duncan G., Wormstone I.M., Davies P.D. The aging human lens: structure, growth, and physiological behaviour. Br. J. Ophthalmol. 1997, 81:818-823.
35. Elanchezhian R., Sakthivel M., Isai M., Geraldine P., Thomas P.A. Evaluation of lenticular antioxidant and redox system components in the lenses of acetyl-L-carnitine treatment in BSO-induced glutathione deprivation. Mol. Vis. 2009, 15:1485-1491.
36. Eshaghian J., Streeten B.W. Human posterior subcapsular cataract. An ultrastructural study of the posteriorly migrating cells. Arch. Ophthalmol. 1980, 98:134-143.
37. Eshagian J. Human posterior subcapsular cataracts. Trans. Ophthalmol. Soc. U. K. 1982, 102(Pt 3):364-368.
38. Fan X. A Putative glutathione transporter identified in mouse lens with glutathione de novo synthesis deficiency (LEGSKO) is also elevated in aged human lens. Association for Research in Vision and Opthalmology Seattle, Washington, USA 2013.
39. Fan X., Wang B., Monnier V.M. Age-related conversion of intra- to intermolecular disulfide crystallin crosslinking. Association for Research in Vision and Ophthalmology Fort Lauderdale, Florida, USA 2012.
40. Fan X.J., Liu X.Q., Hao S.Y., Wang B.L., Robinson M.L., Monnier V.M. The LEGSKO mouse: a mouse model of age-related nuclear cataract based on genetic suppression of lens glutathione synthesis. PLoS One 2012, 7.
41. Freel C.D., Gilliland K.O., Mekeel H.E., Giblin F.J., Costello M.J. Ultrastructural characterization and Fourier analysis of fiber cell cytoplasm in the hyperbaric oxygen treated guinea pig lens opacification model. Exp. Eye Res. 2003, 76:405-415.
42. Fris M., Tessem M.B., Saether O., Midelfart A. Biochemical changes in selenite cataract model measured by high-resolution MAS H NMR spectroscopy. Acta Ophthalmol. Scand. 2006, 84:684-692.
43. Fujii N., Sakaue H., Sasaki H., Fujii N. A rapid, comprehensive liquid chromatography-mass spectrometry (LC-MS)-based survey of the Asp isomers in crystallins from human cataract lenses. J. Biol. Chem. 2012, 287:39992-40002.
44. Fujii N., Takeuchi N., Fujii N., Tezuka T., Kuge K., Takata T., Kamei A., Saito T. Comparison of post-translational modifications of alpha A-crystallin from normal and hereditary cataract rats. Amino Acids 2004, 26:147-152.
45. Garner M.H., Spector A. Selective oxidation of cysteine and methionine in normal and senile cataractous lenses. Proc. Natl. Acad. Sci. U. S. A. 1980, 77:1274-1277.
46. Garner M.H., Spector A. Sulfur oxidation in selected human cortical cataracts and nuclear cataracts. Exp. Eye Res. 1980, 31:361-369.
47. Giblin F.J., David L.L., Wilmarth P.A., Leverenz V.R., Simpanya M.F. Shotgun proteomic analysis of S-thiolation sites of guinea pig lens nuclear crystallins following oxidative stress in vivo. Mol. Vis. 2013, 19:267-280.
48. Giblin F.J., Leverenz V.R., Padgaonkar V.A., Unakar N.J., Dang L., Lin L.R., Lou M.F., Reddy V.N., Borchman D., Dillon J.P. UVA light in vivo reaches the nucleus of the guinea pig lens and produces deleterious, oxidative effects. Exp. Eye Res. 2002, 75:445-458.
49. Giblin F.J., Padgaonkar V.A., Leverenz V.R., Lin L.R., Lou M.F., Unakar N.J., Dang L., Dickerson J.E., Reddy V.N. Nuclear light scattering, disulfide formation and membrane damage in lenses of older guinea pigs treated with hyperbaric oxygen. Exp. Eye Res. 1995, 60:219-235.
50. Giblin F.J., Schrimscher L., Chakrapani B., Reddy V.N. Exposure of rabbit lens to hyperbaric oxygen in vitro: regional effects on GSH level. Investig. Ophthalmol. Vis. Sci. 1988, 29:1312-1319.
51. Gilliland K.O., Freel C.D., Johnsen S., Craig Fowler W., Costello M.J. Distribution, spherical structure and predicted Mie scattering of multilamellar bodies in human age-related nuclear cataracts. Exp. Eye Res. 2004, 79:563-576.
52. Gilliland K.O., Freel C.D., Lane C.W., Fowler W.C., Costello M.J. Multilamellar bodies as potential scattering particles in human age-related nuclear cataracts. Mol. Vis. 2001, 7:120-130.
53. Gilliland K.O., Johnsen S., Metlapally S., Costello M.J., Ramamurthy B., Krishna P.V., Balasubramanian D. Mie light scattering calculations for an Indian age-related nuclear cataract with a high density of multilamellar bodies. Mol. Vis. 2008, 14:572-582.
54. Gong X., Li E., Klier G., Huang Q., Wu Y., Lei H., Kumar N.M., Horwitz J., Gilula N.B. Disruption of alpha3 connexin gene leads to proteolysis and cataractogenesis in mice. Cell 1997, 91:833-843.
55. Gosselin M.E., Kapustij C.J., Venkateswaran U.D., Leverenz V.R., Giblin F.J. Raman spectroscopic evidence for nuclear disulfide in isolated lenses of hyperbaric oxygen-treated guinea pigs. Exp. Eye Res. 2007, 84:493-499.
56. Graw J. Mouse models of cataract. J. Genet. 2009, 88:469-486.
57. Gupta S.K., Srivastava S., Trivedi D., Joshi S., Halder N. Ocimum sanctum modulates selenite-induced cataractogenic changes and prevents rat lens opacification. Curr. Eye Res. 2005, 30:583-591.
58. Hanson S.R.A., Hasan A., Smith D.L., Smith J.B. The major in vivo modifications of the human water-insoluble lens crystallins are disulfide bonds, deamidation, methionine oxidation and backbone cleavage. Exp. Eye Res. 2000, 71:195-207.
59. Harding J.J. Physiology, biochemistry, pathogenesis, and Epidemiology of cataract. Curr. Opin. Ophthalmol. 1991, 2:3-15.
60. Harding J.J. Viewing molecular mechanisms of ageing through a lens. Ageing Res. Rev. 2002, 1:465-479.
61. Harrington V., McCall S., Huynh S., Srivastava K., Srivastava O.P. Crystallins in water soluble-high molecular weight protein fractions and water insoluble protein fractions in aging and cataractous human lenses. Mol. Vis. 2004, 10:476-489.
62. Harrington V., Srivastava O.P., Kirk M. Proteomic analysis of water insoluble proteins from normal and cataractous human lenses. Mol. Vis. 2007, 13:1680-1694.
63. Hooi M.Y.S., Raftery M.J., Truscott R.J.W. Accelerated aging of Asp 58 in alpha A crystallin and human cataract formation. Exp. Eye Res. 2013, 106:34-39.
64. Hooi M.Y.S., Raftery M.J., Truscott R.J.W. Age-dependent racemization of serine residues in a human chaperone protein. Protein Sci. 2013, 22:93-100.
65. Horwitz J. Alpha-crystallin can function as a molecular chaperone. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:10449-10453.
66. Horwitz J. Alpha-crystallin. Exp. Eye Res. 2003, 76:145-153.
67. Hosokawa M., Ashida Y., Tsuboyama T., Chen W.H., Takeda T. Cataract in senescence accelerated mouse (SAM). 2. Development of a new strain of mouse with late-appearing cataract. Exp. Eye Res. 1988, 47:629-640.
68. Hosokawa M., Takeshita S., Higuchi K., Shimizu K., Irino M., Toda K., Honma A., Matsumura A., Yasuhira K., Takeda T. Cataract and other ophthalmic lesions in senescence accelerated mouse (SAM). Morphology and incidence of senescence associated ophthalmic changes in mice. Exp. Eye Res. 1984, 38:105-114.
69. Ihara N. A new strain of rat with an inherited cataract. Experientia 1983, 39:909-911.
70. Ito K. Frontiers of model animals for neuroscience: two prosperous aging model animals for promoting neuroscience research. Exp. Anim. 2013, 62:275-280.
71. Jacob T.J. The relationship between cataract, cell swelling and volume regulation. Prog. Retin. Eye Res. 1999, 18:223-233.
72. Jeganathan V.S.E., Wang J.J., Wong T.Y. Ocular associations of diabetes other than diabetic retinopathy. Diabetes Care 2008, 31:1905-1912.
73. Kannan R., Santhoshkumar P., Mooney B.P., Sharma K.K. The alpha A66-80 peptide interacts with soluble alpha-crystallin and induces its aggregation and precipitation: a contribution to age-related cataract formation. Biochemistry US 2013, 52:3638-3650.
74. Kannan R., Yi J.R., Zlokovic B.V., Kaplowitz N. Molecular characterization of a reduced glutathione transporter in the lens. Investig. Ophthalmol. Vis. Sci. 1995, 36:1785-1792.
75. Kelly S.P., Thornton J., Edwards R., Sahu A., Harrison R. Smoking and cataract: review of causal association. J. Cataract Refract. Surg. 2005, 31:2395-2404.
76. Kolosova N.G., Lebedev P.A., Aidagulova S.V., Morozkova T.S. OXYS rats as a model of senile cataract. Bull. Exp. Biol. Med. 2003, 136:415-419.
77. Kuck J.F. Late onset hereditary cataract of the emory mouse. A model for human senile cataract. Exp. Eye Res. 1990, 50:659-664.
78. Kuck J.F., Kuck K.D. The Emory mouse cataract: loss of soluble protein, glutathione, protein sulfhydryl and other changes. Exp. Eye Res. 1983, 36:351-362.
79. Kuck J.F.R., Kuwabara T., Kuck K.D. The Emory mouse cataract - an animal-model for human senile cataract. Curr. Eye Res. 1982, 1:643-649.
80. Kumar P.A., Reddy G.B. Modulation of alpha-crystallin chaperone activity: a target to prevent or delay cataract?. IUBMB life 2009, 61:485-495.
81. Kwok L.S., Coroneo M.T. Temporal and spatial growth patterns in the normal and cataractous human lens. Exp. Eye Res. 2000, 71:317-322.
82. Kyselova Z. Different experimental approaches in modelling cataractogenesis: an overview of selenite-induced nuclear cataract in rats. Interdiscip. Toxicol. 2010, 3:3-14.
83. Li W., Calvin H.I., David L.L., Wu K., McCormack A.L., Zhu G.P., Fu S.C. Altered patterns of phosphorylation in cultured mouse lenses during development of buthionine sulfoximine cataracts. Exp. Eye Res. 2002, 75:335-346.
84. Lillig C.H., Berndt C., Vergnolle O., Lonn M.E., Hudemann C., Bill E., Holmgren A. Characterization of human glutaredoxin 2 as iron-sulfur protein: a possible role as redox sensor. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:8168-8173.
85. Londahl M., Katzman P., Nilsson A., Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care 2010, 33:998-1003.
86. Lou M.F. Protein-thiol mixed disulfides and thioltransferase in the lens - a review. Adv. Ocular Toxicol. 1997, 27-46.
87. Lou M.F. Thiol regulation in the lens. J. Ocul. Pharmacol. Ther. 2000, 16:137-148.
88. Lou M.F. Redox regulation in the lens. Prog. Retin. Eye Res. 2003, 22:657-682.
89. Lou M.F., Dickerson J.E. Protein-thiol mixed disulfides in human lens. Exp. Eye Res. 1992, 55:889-896.
90. Lou M.F., Dickerson J.E., Garadi R. The role of protein-thiol mixed disulfides in cataractogenesis. Exp. Eye Res. 1990, 50:819-826.
91. Lou M.F., Dickerson J.E., Tung W.H., Wolfe J.K., Chylack L.T. Correlation of nuclear color and opalescence with protein S-thiolation in human lenses. Exp. Eye Res. 1999, 68:547-552.
92. Lundberg M., Johansson C., Chandra J., Enoksson M., Jacobsson G., Ljung J., Johansson M., Holmgren A. Cloning and expression of a novel human glutaredoxin (Grx2) with mitochondrial and nuclear isoforms. J. Biol. Chem. 2001, 276:26269-26275.
93. Manikandan R., Thiagarajan R., Beulaja S., Chindhu S., Mariammal K., Sudhandiran G., Arumugam M. Anti-cataractogenic effect of curcumin and aminoguanidine against selenium-induced oxidative stress in the eye lens of Wistar rat pups: an in vitro study using isolated lens. Chem. Biol. Interact. 2009, 181:202-209.
94. Marsili S., Salganik R.I., Albright C.D., Freel C.D., Johnsen S., Peiffer R.L., Costello M.J. Cataract formation in a strain of rats selected for high oxidative stress. Exp. Eye Res. 2004, 79:595-612.
95. Martensson J., Meister A. Prevention by vitamin-C of the lethal effects of glutathione (Gsh) deficiency induced in newborn rats by administration of buthionine sulfoximine (Bso). Faseb J. 1991, 5. A1183-A1183.
96. Mizuno A., Kanematsu E.H., Suzuki H., Ihara N. Laser Raman spectroscopic study of hereditary cataractous lenses in ICR/f-strain rat. Jpn. J. Ophthalmol. 1988, 32:281-287.
97. Moon R.E. Hyperbaric oxygen treatment for air or gas embolism. Undersea Hyperb. Med. - J. Undersea Hyperb. Med. Soc. Inc. 2014, 41:159-166.
98. Moon R.E. Hyperbaric oxygen treatment for decompression sickness. Undersea Hyperb. Med. - J. Undersea Hyperb. Med. Soc. Inc. 2014, 41:151-157.
99. 2+ regulation in lenses among three hereditary cataract model rats. Biol. Pharm. Bull. 2008, 31:1990-1995.
100. Nakajima E., Walkup R.D., Ma H., Shearer T.R., Azuma M. Low activity by the calpain system in primate lenses causes resistance to calcium-induced proteolysis. Exp. Eye Res. 2006, 83:593-601.
101. Niimi K., Takahashi E. Characterization of senescence-accelerated mouse prone 6 (SAMP6) as an animal model for brain research. Exp. Anim. 2014, 63:1-9.
102. Nishimoto H., Uga S., Miyata M., Ishikawa S., Yamashita K. Morphological study of the cataractous lens of the senescence accelerated mouse. Graefes Arch. Clin. Exp. Ophthalmol. 1993, 231:722-728.
103. Olafsdottir E., Andersson D.K., Stefansson E. The prevalence of cataract in a population with and without type 2 diabetes mellitus. Acta Ophthalmol. 2012, 90:334-340.
104. Olafsdottir E., Andersson D.K.G., Stefánsson E. The prevalence of cataract in a population with and without type 2 diabetes mellitus. Acta Ophthalmol. 2011, 90:334-340.
105. Olofsson E.M., Marklund S.L., Behndig A. Enhanced age-related cataract in copper-zinc superoxide dismutase null mice. Clin. Exp. Ophthalmol. 2012, 40:813-820.
106. Padgaonkar V., Giblin F.J., Reddy V.N. Disulfide cross-linking of urea-insoluble proteins in rabbit lenses treated with hyperbaric oxygen. Exp. Eye Res. 1989, 49:887-899.
107. Padgaonkar V.A., Leverenz V.R., Fowler K.E., Reddy V.N., Giblin F.J. The effects of hyperbaric oxygen on the crystallins of cultured rabbit lenses: a possible catalytic role for copper. Exp. Eye Res. 2000, 71:371-383.
108. Padgaonkar V.A., Lin L.R., Leverenz V.R., Rinke A., Reddy V.N., Giblin F.J. Hyperbaric oxygen in vivo accelerates the loss of cytoskeletal proteins and MIP26 in guinea pig lens nucleus. Exp. Eye Res. 1999, 68:493-504.
109. Palmquist B.M., Philipson B., Barr P.O. Nuclear cataract and myopia during hyperbaric oxygen therapy. Br. J. Ophthalmol. 1984, 68:113-117.
110. Pan C.W., Lin Y. Overweight, obesity, and age-related cataract: a meta-analysis. Optom. Vis. Sci. 2014, 91:478-483.
111. Pirie A. Color and solubility of the proteins of human cataracts. Investig. Ophthalmol. 1968, 7:634-650.
112. Quinlan R. Cytoskeletal competence requires protein chaperones. Prog. Mol. Subcell. Biol. 2002, 28:219-233.
113. Rathbun W.B., Holleschau A.M., Cohen J.F., Nagasawa H.T. Prevention of acetaminophen- and naphthalene-induced cataract and glutathione loss by CySSME. Investig. Ophthalmol. Vis. Sci. 1996, 37:923-929.
114. Rathbun W.B., Kuck J.F.R., Kuck K.D. Glutathione metabolism in lenses of Emory and cataract-resistant mice - activity of 5 enzymes. Curr. Eye Res. 1986, 5:189-194.
115. Reddy V.N. Glutathione and its function in the lens - an overview. Exp. Eye Res. 1990, 50:771-778.
116. Reddy V.N., Giblin F.J., Lin L.R., Dang L., Unakar N.J., Musch D.C., Boyle D.L., Takemoto L.J., Ho Y.S., Knoernschild T., Juenemann A., Lutjen-Drecoll E. Glutathione peroxidase-1 deficiency leads to increased nuclear light scattering, membrane damage, and cataract formation in gene-knockout mice. Investig. Ophthalmol. Vis. Sci. 2001, 42:3247-3255.
117. Rumyantseva Y.V., Fursova A., Fedoseeva L.A., Kolosova N.G. Changes in physicochemical parameters and alpha-crystallin expression in the lens during cataract development in OXYS rats. 5. Biochem. Mosc. 2008, 73:1176-1182.
118. Salganik R.I., Solovyeva N.A., Grishaeva O.N., Dikalov S.I., Semenova L.A., Popovskii A.V. Inherited hyperproduction of free-radicals - pathology of aging. Dokl. Akad. Nauk. 1994, 336:257-260.
119. 2+-induced protein loss, vimentin cleavage and opacification. Investig. Ophthalmol. Vis. Sci. 2000, 41:2255-2261.
120. Sasaki H., Kawakami Y., Ono M., Jonasson F., Shui Y.B., Cheng H.M., Robman L., McCarty C., Chew S.J., Sasaki K. Localization of cortical cataract in subjects of diverse races and latitude. Investig. Ophthalmol. Vis. Sci. 2003, 44:4210-4214.
121. Schein O.D., West S., Munoz B., Vitale S., Maguire M., Taylor H.R., Bressler N.M. Cortical lenticular opacification: distribution and location in a longitudinal study. Investig. Ophthalmol. Vis. Sci. 1994, 35:363-366.
122. Semmens J.B., Li J., Morlet N., Ng J. Trends in cataract surgery and postoperative endophthalmitis in Western Australia (1980-1998): the Endophthalmitis Population Study of Western Australia. Clin. Exp. Ophthalmol. 2003, 31:213-219. teamEpswa.
123. Sharma K.K., Santhoshkumar P. Lens aging: effects of crystallins. Biochim. Biophys. Acta 2009, 1790:1095-1108.
124. Shearer T.R., David L.L., Anderson R.S., Azuma M. Review of selenite cataract. Curr. Eye Res. 1992, 11:357-369.
125. Shearer T.R., Ma H., Fukiage C., Azuma M. Selenite nuclear cataract: review of the model. Mol. Vis. 1997, 3:8.
126. Shearer T.R., Shih M., Mizuno T., David L.L. Crystallins from rat lens are especially susceptible to calpain-induced light scattering compared to other species. Curr. Eye Res. 1996, 15:860-868.
127. Sheets N.L., Chauhan B.K., Wawrousek E., Hejtmancik J.F., Cvekl A., Kantorow M. Cataract- and lens-specific upregulation of ARK receptor tyrosine kinase in Emory mouse cataract. Investig. Ophthalmol. Vis. Sci. 2002, 43:1870-1875.
128. Simpanya M.F., Ansari R.R., Leverenz V., Giblin F.J. Measurement of lens protein aggregation in vivo using dynamic light scattering in a guinea pig/UVA model for nuclear cataract. Photochem. Photobiol. 2008, 84:1589-1595.
129. Simpanya M.F., Ansari R.R., Suh K.I., Leverenz V.R., Giblin F.J. Aggregation of lens crystallins in an in vivo hyperbaric oxygen guinea pig model of nuclear cataract: dynamic light-scattering and HPLC analysis. Investig. Ophthalmol. Vis. Sci. 2005, 46:4641-4651.
130. Solovyova N.A., Ginsburg E.H., Kazarinova F.S., Kandaurov V.V., Salganik R.I. High galactose transport into the cells as the cause of hereditary galactosemia in rats. Vopr. Meditsinskoi Khimii 1987, 33:41-47.
131. Solovyova N.A., Kandaurov V.V., Saidman A.M., Salganik R.I. Hereditary galactosemia in rats - biochemical-mechanisms of the disease development. Vopr. Meditsinskoi Khimii 1982, 28:15.
132. Spector A., Kuszak J.R., Ma W., Wang R.R. The effect of aging on glutathione peroxidase-i knockout mice-resistance of the lens to oxidative stress. Exp. Eye Res. 2001, 72:533-545.
133. Spector A., Roy D. Disulfide-linked high molecular weight protein associated with human cataract. Proc. Natl. Acad. Sci. U. S. A. 1978, 75:3244-3248.
134. Srivastava O.P., Srivastava K. Existence of deamidated alphaB-crystallin fragments in normal and cataractous human lenses. Mol. Vis. 2003, 9:110-118.
135. Stadtman T.C. Biosynthesis and function of selenocysteine-containing enzymes. J. Biol. Chem. 1991, 266:16257-16260.
136. Stewart-DeHaan P.J., Dzialoszynski T., Trevithick J.R. Modelling cortical cataractogenesis XXIV: uptake by the lens of glutathione injected into the rat. Mol. Vis. 1999, 5:37.
137. Takemoto L. Increase in the intramolecular disulfide bonding of alpha-A crystallin during aging of the human. Exp. Eye Res. 1996, 63:585-590.
138. Takemoto L., Kuck J., Kuck K. Changes in the major intrinsic polypeptide (MIP26K) during opacification of the Emory mouse lens. Exp. Eye Res. 1988, 47:329-336.
139. Takemoto L.J., Hansen J.S., Horwitz J. High molecular weight aggregates from human cataracts: characterization by Western blot analysis. Biochem. Biophys. Res. Commun. 1984, 122:1028-1033.
140. Takeuchi N., Kamei A. Crystallin proteins in lenses of hereditary cataractous rat, ICR/f. Biol. Pharm. Bull. 2000, 23:283-290.
141. Takeuchi N., Ouchida A., Kamei A. C-terminal truncation of alpha-crystallin in hereditary cataractous rat lens. Biol. Pharm. Bull. 2004, 27:308-314.
142. Takizawa A., Sasaki K. In vivo observations of cataract development in Emory mouse. Ophthalmic Res. 1986, 18:243-247.
143. Tang Y., Liu X., Zoltoski R.K., Novak L.A., Herrera R.A., Richard I., Kuszak J.R., Kumar N.M. Age-related cataracts in alpha3Cx46-knockout mice are dependent on a calpain 3 isoform. Investig. Ophthalmol. Vis. Sci. 2007, 48:2685-2694.
144. Taylor H.R., West S.K., Rosenthal F.S., Munoz B., Newland H.S., Abbey H., Emmett E.A. Effect of ultraviolet radiation on cataract formation. N. Engl. J. Med. 1988, 319:1429-1433.
145. Taylor V.L., Costello M.J. Fourier analysis of textural variations in human normal and cataractous lens nuclear fiber cell cytoplasm. Exp. Eye Res. 1999, 69:163-174.
146. Teramoto S., Fukuchi Y., Uejima Y., Ito H., Orimo H. Age-related changes in GSH content of eyes in mice - a comparison of senescence-accelerated mouse (SAM) and C57BL/J mice. Comp. Biochem. Physiol. Comp. Physiol. 1992, 102:693-696.
147. Truscott R.J. Age-related nuclear cataract: a lens transport problem. Ophthalmic Res. 2000, 32:185-194.
148. Truscott R.J. Age-related nuclear cataract-oxidation is the key. Exp. Eye Res. 2005, 80:709-725.
149. Truscott R.J., Augusteyn R.C. Changes in human lens proteins during nuclear cataract formation. Exp. Eye Res. 1977, 24:159-170.
150. Truscott R.J., Augusteyn R.C. The state of sulphydryl groups in normal and cataractous human lenses. Exp. Eye Res. 1977, 25:139-148.
151. Velasco P.T., Lukas T.J., Murthy S.N.P., DouglasTabor Y., Garland D.L., Lorand L. Hierarchy of lens proteins requiring protection against heat-induced precipitation by the alpha crystallin chaperone. Exp. Eye Res. 1997, 65:497-505.
152. Weintraub J.M., Willett W.C., Rosner B., Colditz G.A., Seddon J.M., Hankinson S.E. A prospective study of the relationship between body mass index and cataract extraction among US women and men. Int. J. Obes. Relat. Metab. Disord. 2002, 26:1588-1595.
153. Wells P.G., Wilson B., Lubek B.M. In vivo murine studies on the biochemical mechanism of naphthalene cataractogenesis. Toxicol. Appl. Pharmacol. 1989, 99:466-473.
154. West S.K., Longstreth J.D., Munoz B.E., Pitcher H.M., Duncan D.D. Model of risk of cortical cataract in the US population with exposure to increased ultraviolet radiation due to stratospheric ozone depletion. Am. J. Epidemiol. 2005, 162:1080-1088.
155. Wolff S.P. Cataract and Uv-radiation. Doc. Ophthalmol. 1994, 88:201-204.
156. Wu H., Lin L., Giblin F., Ho Y.S., Lou M.F. Glutaredoxin 2 knockout increases sensitivity to oxidative stress in mouse lens epithelial cells. Free Radic. Biol. Med. 2011, 51:2108-2117.
157. Wu H., Yu Y., David L., Ho Y.S., Lou M.F. Glutaredoxin 2 (Grx2) gene deletion induces early onset of age-dependent cataracts in mice. J. Biol. Chem. 2014, 289:36125-36139.
158. Xu G.T., Zigler J.S., Lou M.F. Establishment of a naphthalene cataract model in vitro. Exp. Eye Res. 1992, 54:73-81.
159. Xu G.T., Zigler J.S., Lou M.F. The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (ALO1576). Exp. Eye Res. 1992, 54:63-72.
160. Yagi K., Komura S., Ihara N., Abe H., Konishi H., Arichi S. Serum lipid peroxide levels in rats with inherited cataracts. J. Appl. Biochem. 1985, 7:202-206.
161. Yanshole L.V., Cherepanov I.V., Snytnikova O.A., Yanshole V.V., Sagdeev R.Z., Tsentalovich Y.P. Cataract-specific posttranslational modifications and changes in the composition of urea-soluble protein fraction from the rat lens. Mol. Vis. 2013, 19:2196-2208.
162. Ye J., He J., Wang C., Wu H., Shi X., Zhang H., Xie J., Lee S.Y. Smoking and risk of age-related cataract: a meta-analysis. Investig. Ophthalmol. Vis. Sci. 2012, 53:3885-3895.
163. Zigler J.S. Animal models for the study of maturity-onset and hereditary cataract. Exp. Eye Res. 1990, 50:651-657.